# Palm Tocotrienols in Chronic Hemodialysis (USA)

> **NCT02358967** · NA · COMPLETED · sponsor: **Wayne State University** · enrollment: 280 (actual)

## Conditions studied

- End Stage Renal Disease
- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** TRF (Tocotrienol-rich-fraction)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02358967
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-08-31
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2022-08-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02358967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02358967, "Palm Tocotrienols in Chronic Hemodialysis (USA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02358967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*